Additional file 1. CDG state of the art until 2022: glycosylation pathways, phenotypes, genotypes, inheritance patterns, biomarkers, disease models, and treatments.
Congenital disorders of glycosylation (CDG) are a group of rare metabolic diseases, due to impaired protein and lipid glycosylation. In the present study, exome sequencing was used to identify MAN1B1
Text data of Fig. 7. ESI-Q mass spectrum of transferrin in various types of CDG. A (control), B (PMM2), C (ALG14), D (SLC35A2), E (SLC35A1), F (MAN1B1), G (PGM1) The mass spectral data (.txt or c
ASSOCIATED WITH congenital disorder of glycosylation Ii (ortholog); congenital disorder of glycosylation type II (ortholog); congenital myasthenic syndrome 14 (ortholog); FOUND IN brush border (orthol
